Cizzle Bio has launched full commercial sales of Cizzle Biotechnology's CIZ1B lung cancer blood test in the Dallas-Fort Worth and San Antonio areas, ...
News
- Cizzle Biotechnology's Lung Cancer Blood Test Enters Full Commercial Sales in Key Texas Markets
- bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize ... - StreetInsider
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer ...
- Cizzle Bio Launches CIZ1B Biomarker Blood Test for Early Lung Cancer - PR Newswire
The Dallas-Fort Worth and San Antonio markets were selected for the ... Explore. Biotechnology · Medical ...
- Cizzle Bio Launches CIZ1B Biomarker Blood Test for Early Lung Cancer | Morningstar
DALLAS, July 22, 2026 /PRNewswire/ -- Texas-based Cizzle Bio, Inc., a biotechnology ... The Dallas-Fort Worth and San Antonio markets were selected for ...
- UW To Replace Aging Chem Library With $191M Lab Powerhouse - Hoodline
... biotech and semiconductor manufacturing. Internal materials frame the ... SAN ANTONIO SAN DIEGO SAN FERNANDO VALLEY SEATTLE SOMA SOUTH LOS ...